M16-283
ClinicalTrials.gov NCT03271489
Research payments
$14,792,138
Through program year 2020, $14,792,138 in research payments was reported against M16-283, across 4,550 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03271489
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $3,484,655 | 1,420 |
| 2019 | Research | $11,307,482 | 3,130 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Liesl Smith Dallas, TX Named on 298 payments
- Kwabena Ayesu Orlando, FL Named on 203 payments
- Eric Brown Smyrna, GA Named on 167 payments
- Jose Rodriguez Tampa, FL Named on 135 payments
- James Cain Lampasas, TX Named on 110 payments
- Gregory Swor Sarasota, FL Named on 94 payments
- Tollie Elliott Washington, DC Named on 84 payments
- Kendra Hayslett Martin, TN Named on 83 payments
- Samuel Lederman Lake Worth, FL Named on 73 payments
- Ronald Ackerman West Palm Beach, FL Named on 67 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.